This article has been updated to clarify that the bankruptcy filing only applies to the Gene Logic subsidiary.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ocimum Biosolutions, doing business as Gene Logic, has filed for Chapter 11 bankruptcy protection, and is seeking a buyer for its assets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The Guardian discusses whether big science projects are worth the loss of resources available for other scientific pursuits.

An NEJM update from the ClinVar team highlights the difficulties of interpreting genetic variants.